CIK 0001603454 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -177.0 M | -63.8 M | -40.4 M |
| Diluted EPS (USD/shares) | -3.79 | -2.69 | -2.64 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-09 | 4 | 4 | 2026-10-07 |
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-10-05 | 3 | 3 | 2026-10-01 |
| 2026-10-02 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-10-01 |
| 2026-09-30 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-30 |
| 2026-08-26 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-08-26 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-13 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-13 | 8-K | 8-K items 2.02,9.01 | 2026-08-13 |
| 2026-08-11 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-16 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-16 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-16 | 4 | 4 | 2026-07-14 |
| 2026-07-15 | 8-K/A | 8-K/A items 7.01,8.01,9.01 | 2026-07-14 |
| 2026-07-15 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-07-14 |
| 2026-07-14 | 144 | 144 | |
| 2026-07-14 | 144 | 144 | |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
Forms on file (last 1,000): 4 173, 8-K 89, SC 13G/A 28, 10-Q 27, D/A 21, 144 18, 424B5 15, 3 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CELC (0.002 USD), /gw/filings/filings?ticker=CELC&form=8-K, /gw/filings/facts?ticker=CELC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange